{
    "title": "GSK expects US launch of RSV vaccine with no supply issues",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11839247/GSK-expects-US-launch-RSV-vaccine-no-supply-issues.html",
    "date": "2023-03-09",
    "keywords": [
        "vaccine",
        "gsk",
        "rsv",
        "pfizer",
        "respiratory",
        "dormitzer",
        "efficacy",
        "market",
        "disease",
        "maggie",
        "virus",
        "year",
        "supply",
        "future",
        "shot",
        "executive",
        "drugmaker",
        "approval",
        "advantage",
        "trial",
        "china",
        "shingrix",
        "company",
        "march",
        "inc",
        "week",
        "panel",
        "food",
        "drug",
        "administration",
        "fda",
        "decision",
        "capacity",
        "research",
        "amp",
        "development",
        "interview",
        "wednesday",
        "launch",
        "plant",
        "belgium",
        "latestage",
        "health",
        "consistency",
        "tract",
        "illness",
        "analysis",
        "age",
        "group",
        "comparison",
        "partner",
        "biontech",
        "rsvflu",
        "coadministration",
        "interest",
        "companys",
        "emma",
        "walmsley",
        "potential",
        "union",
        "japan",
        "world",
        "reporting",
        "grover",
        "editing",
        "bill",
        "berkrot",
        "sharon",
        "singleton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}